PASSERI DANIEL R 4
4 · Cue Biopharma, Inc. · Filed Oct 8, 2021
Insider Transaction Report
Form 4
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2021-09-30+75,000→ 130,377 total - Tax Payment
Common Stock
2021-09-30$14.57/sh−31,677$461,534→ 98,700 total - Exercise/Conversion
Restricted Stock Units
2021-09-30−75,000→ 75,000 total→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]One half of the Restricted Stock Units vested on September 30, 2021 and the balance will vest on March 31, 2022.